Literature DB >> 30120646

Outcomes of Clostridium difficile-suspected diarrhea in a French university hospital.

Nagham Khanafer1,2, Philippe Vanhems3,4, Frédéric Barbut5,6, Catherine Eckert5,6, Michel Perraud3, François Vandenesch7, Christine Luxemburger8, Clarisse Demont8.   

Abstract

Clostridium difficile infection (CDI) produces a variety of clinical presentations ranging from mild diarrhea to severe infection with fulminant colitis, septic shock, and death. CDI puts a heavy burden on healthcare systems due to increased morbidity and mortality, and higher costs. We evaluated the clinical impact of CDI in terms of complications and mortality in a French university hospital compared with patients with diarrhea unrelated to CDI. A 3-year prospective, observational, cohort study was conducted in a French university hospital. Inpatients aged 18 years or older with CDI-suspected diarrhea were eligible to participate in the study and were followed for up to 60 days after CDI testing. Among the 945 patients with diarrhea included, 233 had confirmed CDI. Overall, 106 patients (11.2%) developed at least one of the following complications: colectomy, colitis, ileitis/rectitis, ileus, intestinal perforation, megacolon, multiorgan failure, pancolitis, peritonitis, pseudomembranous colitis, renal failure, and sepsis/septic shock. The complication rate was significantly higher in patients with diarrhea related to C. difficile than in non-CDI patients (26.6% vs 6.2%, P < 0.001). At day 60, 137 (14.5%) patients had died, with 37 deaths among the CDI group (15.9%). Death was attributable to CDI in 15 patients (6.4%). Complications are more frequent among CDI cases than in patients with diarrhea not related to C. difficile. Assessment of CDI is necessary to ensure allocation of sufficient resources to CDI prevention.

Entities:  

Keywords:  Clostridium difficile infection; Complication; Prognosis; Recurrence; Ribotype

Mesh:

Year:  2018        PMID: 30120646     DOI: 10.1007/s10096-018-3348-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Risk factors associated with complications and mortality in patients with Clostridium difficile infection.

Authors:  Rosemary H Morrison; Natalie S Hall; Mina Said; Tamar Rice; Harold Groff; Stephanie K Brodine; Donald Slymen; Edith R Lederman
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

2.  [Problems of geriatric surgery and postoperative care].

Authors:  E Blum
Journal:  ZFA (Stuttgart)       Date:  1976-02-10

3.  [Spontaneous bilio-digestive fistula of lithiasic etiology. Experience of 41 cases].

Authors:  M Cesari; A Balzola; O Giordano; P Vocino
Journal:  Minerva Chir       Date:  1989-03-15       Impact factor: 1.000

4.  Information holds medicine together.

Authors:  M S Blois
Journal:  MD Comput       Date:  1987 Sep-Oct

5.  Who'll nurse the nurses?

Authors:  N Amidel
Journal:  Fla Nurse       Date:  1987-05

6.  In memoriam. Joseph E. Johnson (1888-1969).

Authors:  W Gray
Journal:  Am J Orthod       Date:  1970-04

7.  [Colo-rectal neoplasms: indications for radiotherapy].

Authors:  E M Röttinger; H Sack
Journal:  MMW Munch Med Wochenschr       Date:  1979-05-04

8.  Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Authors:  Claire Nour Abou Chakra; Allison McGeer; Annie-Claude Labbé; Andrew E Simor; Wayne L Gold; Matthew P Muller; Jeff Powis; Kevin Katz; Julian R Garneau; Louis-Charles Fortier; Jacques Pépin; Suzanne M Cadarette; Louis Valiquette
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

9.  Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Authors:  Carolyn V Gould; Jonathan R Edwards; Jessica Cohen; Wendy M Bamberg; Leigh Ann Clark; Monica M Farley; Helen Johnston; Joelle Nadle; Lisa Winston; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 20.999

10.  Clinical risk factors for severe Clostridium difficile-associated disease.

Authors:  Timothy J Henrich; Douglas Krakower; Asaf Bitton; Deborah S Yokoe
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more
  2 in total

1.  Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.

Authors:  T J Carlson; D Blasingame; A J Gonzales-Luna; F Alnezary; K W Garey
Journal:  Anaerobe       Date:  2019-12-19       Impact factor: 3.331

2.  Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové.

Authors:  Kristýna Vaverková; Martin Kracík; Lenka Ryšková; Pavla Paterová; Rudolf Kukla; Lenka Hobzová; Roman Špánek; Helena Žemličková
Journal:  Antibiotics (Basel)       Date:  2021-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.